
WEBINAR
Only
The Quest for a COVID-19 Vaccine
Tuesday, February 2, 2021, 10:00 AM - Wednesday, February 3, 2021, 5:35 PM EST
Webinar
The world is undergoing a global public health disaster unlike anything experienced since the 1918 influenza pandemic. COVID-19 disease — which emerged from the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) — rapidly has spread from person to person across all borders. With no “silver bullet” treatment currently available, the novel coronavirus pandemic has caused substantial morbidity and mortality worldwide.
Scientific researchers therefore have raced at an unprecedented pace to develop vaccines against SARS-CoV-2. The importance of vaccines is two-fold: they prevent disease in the individual receiving the inoculation and the best vaccines are also able to block a pathogen’s transmission from person to person. Academia, biotechnology, and government swiftly mobilized to develop candidate vaccines for SARS-CoV-2, several of which are now in use worldwide. The field of vaccinology has demonstrated significant innovation in harnessing both traditional vaccine techniques and cutting-edge/not-yet-proven strategies as they seek to build an effective vaccine for SARS-CoV-2. The sheer number of groups developing a vaccine, the diversity of candidate vaccines being explored, the range of technology platforms, and the enormous financial investment into these activities are all historic and hopefully will lead to additional efficacious licensed vaccines. Despite recent successes, critical open questions and hurdles remain.
The world is waiting for more SARS-CoV-2 vaccines and hoping that multiple vaccines collectively will help control the current pandemic. Moreover, the recent development a SARS-CoV-2 vaccine was the fastest in history. This will open new innovation windows that we can learn from for the future. This conference will provide a neutral forum to explore recent achievements and challenges in the development of a vaccine against SARS-CoV-2. Through a series of keynote and plenary presentations, major themes to be considered for the program include:
- the clinical epidemiology of COVID-19
- the virology, immunology, and genetics of SARS-CoV-2,
- efficacy data updates from candidate vaccines in Phase 3 trials,
- updates from Phase 1 and 2 vaccine candidates,
- COVID-19 vaccines in the elderly,
- outbreak predictions, and
- future considerations for the development and distribution of a COVID-19 vaccine
Registration
Gold Sponsors
Bronze Sponsor
Promotional Partners
Tuesday
February 02, 2021
WELCOME REMARKS
Speaker
KEYNOTE ADDRESS
Speakers
KEYNOTE ADDRESS: The Year in Review: A Vaccinologist’s Perspective
Speakers
Break
SESSION I: Epidemiology of COVID-19
Tracking Changes in SARS-CoV-2 Spike
Speaker
SESSION II: Virology, Immunology, & Genetics of SARS-CoV-2
Virology of SARS-CoV-2
Speaker
Immunology of SARS-CoV-2
Speaker
Break
Longitudinal Immune Profiling of Moderate and Severe COVID-19
Speaker
SESSION III: Efficacy Studies, Part 1
Efficacy Data Updates from Moderna’s mRNA Vaccine Candidate
Speaker
Efficacy Data Updates from the Pfizer-BioNTech mRNA Vaccine Candidate
Speaker
Break
Efficacy Data Updates from Novavax’s Protein-based Vaccine Candidate
Speaker
SESSION IV: Update Talks
Updates from Codagenix’s Vaccine Candidate
Speaker
Development of DNA-Based COVID-19 Vaccine
Speaker
SESSION V: Day 1 Closing Talk
The Role of Modern Vaccinology in Responding to New Epidemics
Speaker
Closing Remarks, Day 1
End of Day
Wednesday
February 03, 2021
WELCOME REMARKS
Speaker
SESSION VI: Efficacy Studies, Part 2
Update on ChAdOx1 nCoV-19/AZD1222
Speaker
Efficacy Data Updates from CanSino Biologics’ Viral-Vector Vaccine Candidate
Speaker
Break
Janssen’s Effort in the Development of an Ad26 Based COVID-19 Vaccine
Speaker
SESSION VII: Update Talks
Updates from Valneva's Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Speaker
Updates from CureVac’s Messenger RNA (mRNA)-based Covid-19 Vaccine Candidate
Speaker
Low Cost Recombinant Protein COVID19 Vaccine for Global Health
Speaker
Vaxart’s Oral Covid-19 Vaccine - Clinical Trial Update
Speaker
Break
SESSION VIII: COVID-19 Vaccines in the Elderly
Immunosenescence and COVID-19 Vaccines for the Elderly
Speaker
SESSION IX: Outbreak Predictions
How to Make Predictions about Future Infectious Disease Risks
Speaker
Challenges to Prediction and Prevention of the Next Pandemic Zoonosis
Speaker
SESSION X: Future Considerations
Progress in Novel Treatments for COVID-19 and Beyond
Speaker
Lessons Learned from COVID-19 Vaccine Development for Future Pandemic Preparedness
Speaker
Access, Deployment, and Global Distribution Challenges for COVID-19 Vaccines
Speaker
The Plague Year of 2020 and Its Effect on Vaccinology
Speaker
Closing Remarks, Day 2
Speaker